Valuation: USANA Health Sciences, Inc.

Market Cap 245M 222M 205M 185M 349M 23.08B 361M 2.46B 977M 12.33B 919M 899M 39.14B P/E 2026 *
-14.7x
P/E 2027 * 17.2x
Enterprise Value 245M 222M 205M 185M 349M 23.08B 361M 2.46B 977M 12.33B 919M 899M 39.14B EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.27x
Free-Float
59.03%
Yield 2026 *
-
Yield 2027 * -
1 day+4.01%
1 week-2.86%
Current month-7.48%
1 month-13.29%
3 months-0.97%
6 months-26.28%
Current year-32.55%
1 week 12.52
Extreme 12.525
14.34
1 month 12.52
Extreme 12.525
15.89
Current year 12.52
Extreme 12.525
23.59
1 year 12.52
Extreme 12.525
23.59
3 years 12.52
Extreme 12.525
54.81
5 years 12.52
Extreme 12.525
103.95
10 years 12.52
Extreme 12.525
137.95
Manager TitleAgeSince
Chief Executive Officer 63 2026-01-07
Director of Finance/CFO 56 2017-04-30
Chief Tech/Sci/R&D Officer 45 2024-06-30
Director TitleAgeSince
Chairman 85 1992-08-31
Director/Board Member 85 2008-08-31
Chairman 63 2020-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
10/22/26 Exercice

Director

3,264 0.0177%
10/22/26 Exercice

Director

3,868 0.0209%
10/22/26 Exercice

Director

3,264 0.0177%
Change 5-day change 1-year change 3-year change Capi.($)
+4.01%-2.86%-31.01%-71.56% 245M
+1.33%+2.18%+9.23%-11.75% 269B
+1.47%+2.30%+18.78%-3.65% 85.49B
+1.31%+3.99%-11.13%+20.10% 49.55B
0.00%0.00%+21.67%+566.67% 43.24B
+0.57%-2.14%-2.75%-11.91% 35.02B
+2.72%+4.19%+24.38%-1.30% 34.69B
+2.39%+0.92%+11.96%+16.39% 30.08B
+0.61%-2.49%-9.19%-9.02% 29.8B
+2.57%+2.03%+1.05%-25.22% 29.73B
Average +1.70%+0.77%+3.30%+46.87% 61B
Weighted average by Cap. +1.37%+1.48%+8.79%+34.62%

Financials

2026 *2027 *
Net sales 899M 815M 754M 680M 1.28B 84.77B 1.33B 9.05B 3.59B 45.28B 3.37B 3.3B 144B 917M 831M 769M 693M 1.31B 86.45B 1.35B 9.23B 3.66B 46.18B 3.44B 3.37B 147B
Net income -16.5M -14.95M -13.83M -12.48M -23.51M -1.56B -24.34M -166M -65.87M -831M -61.92M -60.6M -2.64B 14.18M 12.85M 11.89M 10.73M 20.21M 1.34B 20.93M 143M 56.63M 714M 53.22M 52.1M 2.27B
Net Debt - -
Projected Income Statement - Annual - USANA Health Sciences, Inc.
Logo USANA Health Sciences, Inc.
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures nutritional supplements, functional foods and personal care products. Its segments include Core nutritional and Hiya direct-to-consumer. The Core nutritional segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the core nutritional channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal care and Skincare, and All other. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3.
Employees
1,570
Date Price Change Volume
26-11-13 US$13.24 +4.01% 167,451
26-11-12 US$12.73 -0.93% 201,594
26-11-11 US$12.85 -1.91% 188,229
26-11-10 US$13.10 -5.42% 246,911
26-11-09 US$13.85 +1.61% 258,009
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
MarketScreener Ratings - USANA Health Sciences, Inc.
  1. Stock Market
  2. Stocks
  3. USNA Stock